Welcome to LookChem.com Sign In|Join Free

CAS

  • or

15717-45-0

Post Buying Request

15717-45-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

15717-45-0 Usage

Chemical Properties

Yellow Solid

Check Digit Verification of cas no

The CAS Registry Mumber 15717-45-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,7,1 and 7 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 15717-45:
(7*1)+(6*5)+(5*7)+(4*1)+(3*7)+(2*4)+(1*5)=110
110 % 10 = 0
So 15717-45-0 is a valid CAS Registry Number.

15717-45-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 2',3',5-TRI-O-ACETYL-8-BROMOGUANOSINE

1.2 Other means of identification

Product number -
Other names 2'-O,3'-O,5'-O-Triacetyl-8-bromoguanosine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:15717-45-0 SDS

15717-45-0Relevant articles and documents

A novel nitration product formed during the reaction of peroxynitrite with 2',3',5'-tri-O-acetyl-7,8-dihydro-8-oxoguanosine: N-nitro-N'-[1-(2,3,5- tri-O-acetyl-β-D-erythro-pentofuranosyl)-2,4-dioxoimidazolidin-5- ylidene]guanidine

Niles, Jacquin C.,Wishnok, John S.,Tannenbaum, Steven R.

, p. 390 - 396 (2000)

A novel nitration product, formed during the reaction of peroxynitrite with 2',3',5'-tri-O-acetyl-7,8-dihydro-8-oxoguanosine, has been characterized using a combination of UV/vis, CD, and NMR spectroscopy and mass spectrometry. This compound has been identified as N-nitro-N'-[1-(2,3,5-tri- P-O-acetyl-β-D-erythro-pentofuranosyl)-2,4-dioxoimidazolin-5- ylidene]guanidine (IV). Upon base hydrolysis, IV releases nitroguanidine (IVa) and an intermediate, 1-(2,3,5-tri-O-acetyl-β-D-erythro- pentofuranosyl)-5-iminoimidazolidine-2,4-dione (IVb). This intermediate is ultimately hydrolyzed to the stable 3-(2,3,5-tri-O-acetyl-β-D-erythro- pentofuranosyl)oxaluric acid (IVc). IV can be reduced by sodium borohydride to a pair of stable diastereomers (IV(red)). The formation of this product is rationalized in terms of initial oxidation of 2',3',5'-tri-O-acetyl-7,8- dihydro-8-oxoguanosine to a quinonoid diimine intermediate, 3. Nucleophilic attack at C5 of 3 by peroxynitrite leads to formation of a C5-oxyl radical species, 5, which then undergoes a series of rearrangements to yield an ylidene radical, 7. Combination of this radical species with nitrogen dioxide results in the formation of product IV.

Pyridine-free and solvent-free acetylation of nucleosides promoted by molecular sieves

Sá, Marcus Mandolesi,Meier, Lidiane

, p. 3474 - 3478 (2006)

A practical method for the acetylation of purine and pyrimidine nucleosides employing a combination of acetic anhydride and potassium-exchanged molecular sieves is described. Besides the high yields obtained for the acylated nucleosides, the procedure is simple, inexpensive and environmentally benign, avoiding the use of pyridine or co-solvents as additives. Georg Thieme Verlag Stuttgart.

Synthesis of 8-alkoxy-6-alkylamino-2-alkylthiopurine nucleosides with a straightforward multiple-functionalization strategy

Du, Hongguang,Sun, Xiaoyang,Yu, Mingwu,Tian, Miao,Li, Shunlai,Wang, Zhiqian

supporting information, p. 2949 - 2953 (2016/07/06)

A straight forward strategy to synthesize purine nucleosides with multiple functionalization on 2-, 6-, and 8-positions has been developed successfully, which provides a series of 8-alkoxy-6-alkylamino-2-alkylthiopurine nucleosides in moderate to good yields for further biological and medical activity screening.

RNA INCLUDING NUCLEOSIDE COMPOUND, METHOD FOR REGULATING AMOUNT OF PROTEIN PRODUCED FROM THE RNA, AND NUCLEOSIDE COMPOUND

-

Page/Page column, (2013/03/26)

An RNA of the present invention is an RNA containing a 5′ cap structure and a coding region having a 5′ initiation codon and a 3′ stop codon on both ends of the coding region, the RNA having a nucleoside compound introduced at a site selected from among the 5′ cap structure and 10 bases from a 5′ end of the RNA, wherein the nucleoside compound is such that a group is attached to (i) a carbon atom at position 8 of a purine nucleus or (ii) a carbon atom at position 5 or 6 of a pyrimidine nucleus, the group being represented by formula (I): [in-line-formulae]A-X═X-#??(I)[/in-line-formulae] where A represents an aryl group or a heteroaryl group, # represents a site where the group represented by the formula (I) is attached to the carbon atom at the position 8 of the purine nucleus or the carbon atom at the position 5 or 6 of the pyrimidine nucleus, and two Xs, which are identical to or different from each other, each represents a nitrogen atom or CH whose H may be substituted by alkyl.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 15717-45-0